LOOMIS SAYLES & CO L PLOOMIS SAYLES & CO L P

Institutional investor · Portfolio as of Q1 2023

Top Holdings974 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

NVIDIA CORP

11.5M$3.2B5.6%$16.58+65.02%
17 qtrssince 2019-Q1
Decreased
0

META PLATFORMS INC-CLASS A

14.5M$3.1B5.3%$138.14+49.42%
18 qtrssince 2018-Q4
Increased
63

VISA INC-CLASS A SHARES

11.1M$2.5B4.4%$131.58+66.84%
18 qtrssince 2018-Q4
Decreased
0

BOEING CO/THE

11.6M$2.5B4.3%$181.12+17.29%
18 qtrssince 2018-Q4
Decreased
0

AMAZON.COM INC

22.8M$2.4B4.1%$106.79-4.48%
18 qtrssince 2018-Q4
Increased
63

MICROSOFT CORP

7.1M$2.1B3.6%$98.70+184.20%
18 qtrssince 2018-Q4
Decreased
0

TESLA INC

9.6M$2B3.5%$221.88-11.99%
11 qtrssince 2020-Q3
Increased
68

ALPHABET INC-CL A

18.8M$1.9B3.4%$94.58+5.87%
18 qtrssince 2018-Q4
Increased
59

ORACLE CORP

20.7M$1.9B3.3%$40.87+113.62%
18 qtrssince 2018-Q4
Decreased
0

NETFLIX INC

4.9M$1.7B2.9%$29.20+15.89%
11 qtrssince 2020-Q3
Decreased
0

SALESFORCE.COM INC

8.2M$1.6B2.9%$172.07+14.13%
13 qtrssince 2020-Q1
Decreased
0

MONSTER BEVERAGE CORP

28M$1.5B2.6%$39.25+37.61%
18 qtrssince 2018-Q4
Increased
87

AUTODESK INC

6.7M$1.4B2.4%$131.92+57.80%
18 qtrssince 2018-Q4
Decreased
0

WALT DISNEY CO/THE

11.1M$1.1B1.9%$133.44-28.18%
18 qtrssince 2018-Q4
Decreased
0

REGENERON PHARMACEUTICALS

1.3M$1.1B1.9%$360.72+125.66%
18 qtrssince 2018-Q4
Decreased
0

VERTEX PHARMACEUTICALS INC

3.4M$1.1B1.8%$186.49+67.39%
14 qtrssince 2019-Q4
Decreased
0

STARBUCKS CORP

9.3M$968.3M1.7%$62.88+52.00%
18 qtrssince 2018-Q4
Decreased
0

QUALCOMM INC

6.6M$843.8M1.5%$48.19+148.45%
18 qtrssince 2018-Q4
Decreased
0

ALPHABET INC-CL C

7.9M$818.9M1.4%$94.90+5.98%
18 qtrssince 2018-Q4
Decreased
0

ILLUMINA INC

3.4M$793.4M1.4%$300.65-27.12%
13 qtrssince 2020-Q1
Increased
53
$57.6B
AUM
974
Positions
Q1 2023
Filing
4.5/5
HI score
Quarterly 13F Value Change
+2%Q4'21$82.7B-9%Q1'22$74.8B-28%Q2'22$53.9B-8%Q3'22$49.4B+1%Q4'22$49.9B+15%Q1'23$57.6B
Activity profile
$ moved · Q1'23
New11%Increased36%Decreased49%Exited4%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.8 years
<1Q8%1-4Q9%1-2Y15%2Y+69%

LOOMIS SAYLES & CO L P manages $57.6B across 974 positions as of Q1 2023. Top holdings: NVDA (5.6%), META (5.3%), V (4.4%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4.5/5.0.

Q1 2023 Summary

Active quarter - 204 new positions, 82 exits, 278 increased. Top move: MNST (INCREASED, conviction 87). Portfolio: $57.6B across 974 positions.

Top holdings by portfolio weight

Total AUM$58B
NVDA5.56%
META5.32%
V4.36%
BA4.26%
AMZN4.09%
MSFT3.57%
TSLA3.45%
GOOGL3.38%
ORCL3.33%
NFLX2.91%
Other2.85%

Portfolio allocation by GICS sector

Sectors11
Technology26.85%
Consumer Cyclical15.78%
Communication Services15.57%
Healthcare13.34%
Financial Services10.92%
Industrials9.81%
Consumer Defensive4.15%
Unknown1.42%
Energy1.11%
Basic Materials0.79%
Other0.25%

Behavioral investing profile

7-dimension, SEC 13F-derived research score
Elite(4.5 / 5.0)
Holdings P&L68
Conviction40
Concentration80
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
BKNGBKNGBOOKING HOLDINGS INC
Q3 2024 Q2 2026+3.4M shares+$607.5M
6Q
CEMBCEMBISHARES INC
Q1 2025 Q2 2026+144,626 shares+$6.8M
5Q
TTTTINGERSOLL-RAND PLC
Q2 2025 Q2 2026+284,022 shares+$187M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used